Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-29 | Dr. Nova holds a B.S. in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside. Dr. Nova’s extensive leadership, business and scientific expertise in the biopharmaceutical and diagnostics industries, and her experience in successfully developing, launching and commercializing medical products contributed to our Board's conclusion that she should serve as a director of our company. |
| 2021-04-27 | Dr. Nova holds a B.S. in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside. Dr. Nova’s extensive leadership, business and scientific expertise in the biopharmaceutical and diagnostics industries, and her experience in successfully developing, launching and commercializing medical products contributed to our Board's conclusion that she should serve as a director of our company. |
| 2022-04-28 | Dr. Nova holds a B.S. in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside. Dr. Nova’s extensive leadership, business and scientific expertise in the biopharmaceutical and diagnostics industries, and her experience in successfully developing, launching, and commercializing medical products contributed to our Board's conclusion that she should serve as a director of our company. |
| 2023-04-28 | Dr. Nova holds a B.S. in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside. Dr. Nova’s extensive leadership, business and scientific expertise in the biopharmaceutical and diagnostics industries contributed to our Board's conclusion that she should serve as a director of our Company. |
| 2024-04-26 | She holds a B.S. in Biological Sciences from the University of California, Irvine and a Ph.D. in Biochemistry from the University of California, Riverside. |
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-26 | Dr. Nova holds a B.S. in Biological Sciences and a Ph.D. in Biochemistry, with leadership roles in genomics-based businesses, but no software or programming background mentioned. |
| 2017-12-18 | Tina S. Nova, Ph.D.: Consists of stock options to purchase 9,375 shares of common stock that are currently vested or that will become vested within 60 days. |
| 2018-04-30 | Dr. Nova is a life science industry veteran with extensive experience building and leading novel genomics-based businesses. She holds a B.S. degree in Biological Sciences from the University of California, Irvine, and a Ph.D. in Biochemistry from the University of California, Riverside. |
| 2019-07-12 | She holds a B.S. degree in Biological Sciences from the University of California, Irvine, and a Ph.D. in Biochemistry from the University of California, Riverside. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22